This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hormel Foods (HRL) Q1 Earnings & Sales Beat on Brand Strength
by Zacks Equity Research
Hormel Foods' (HRL) first-quarter fiscal 2022 results reflect higher net sales and earnings driven by brand strength, higher pricing and continued recovery in the foodservice unit.
Things to Consider Before Inter Parfums' (IPAR) Q4 Earnings
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2021 performance is likely to reflect sales growth on strength in U.S. and European operations.
Keurig Dr Pepper (KDP) Q4 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q4 results gain from solid consumer demand and improvement in the away-from-home channel. Management issues an upbeat 2022 view.
Molson Coors (TAP) Q4 Earnings Miss Estimates on Inflation
by Zacks Equity Research
Molson Coors' (TAP) Q4 results reflect continued progress on its revitalization plan and premiumization efforts. However, inflationary pressure and supply-chain woes remain concerning.
Nu Skin (NUS) Q4 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2021 earnings and revenues decline year over year. Management offers a drab view for the first quarter.
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 16.84% and 2.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Cosmetics Stocks Worth Watching on Robust Industry Trends
by Vrishali Bagree
The Zacks Cosmetics industry benefits from increased makeup and skincare demand. Also, focus on innovation and product launches is aiding Estee Lauder (EL), Coty (COTY), Helen of Troy (HELE) and Inter Parfums (IPAR).
High Demand & Nutrition Unit to Aid Archer Daniels (ADM)
by Zacks Equity Research
Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including portfolio expansion and strategic partnerships.
Flowers Foods (FLO) Q4 Earnings Miss Estimates, Costs Rise
by Zacks Equity Research
Flowers Foods (FLO) fourth-quarter fiscal 2021 results reflect a decline in the top and bottom lines. Although the operating landscape remains tough, early fiscal 2022 results raise optimism.
Conagra (CAG) Gains on Pricing Initiatives Amid Cost Woes
by Zacks Equity Research
Conagra Brands (CAG) has been benefiting from its pricing initiatives along with the recovery of its foodservice business. These have been aiding the company amid rising costs.
Coca-Cola (KO) Stock Rises on Q4 Earnings & Revenue Beat
by Zacks Equity Research
Coca-Cola's (KO) Q4 results reflect gains from recovery across markets and strategic transformation. KO also issues an encouraging 2022 view.
Will Procter & Gamble (PG) Retain Its Upside Story in 2022?
by Zacks Equity Research
Although high costs remain concerning, Procter & Gamble (PG) seems well-placed for long-term growth on robust demand and productivity plans. A raised fiscal 2022 view drives optimism.
Coty (COTY) Beats on Q2 Earnings, Raises Bottom-line View
by Zacks Equity Research
Coty's (COTY) second-quarter fiscal 2022 results reflect higher earnings and revenues on growth across all regions and channels. Management raises fiscal 2022 earnings view.
Energizer (ENR) Q1 Earnings & Sales Beat on Solid Demand
by Zacks Equity Research
Solid results in the auto care business, pricing gains and cost-control measures aid Energizer's (ENR) first-quarter fiscal 2021 results. However, input cost inflation remains a drag.
Coty (COTY) Q2 Earnings Top Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 41.67% and 2.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Dips as Q2 Earnings Lag Estimates, Lowers View
by Zacks Equity Research
Clorox (CLX) Q2 results hurt by soft sales performance across all segments, led by lower shipment volumes. Higher costs also hurt the bottom line.
The Estee Lauder Companies (EL) Beats on Earnings in Q2
by Zacks Equity Research
The Estee Lauder Companies' (EL) second-quarter fiscal 2022 sales and earnings rise year over year on growth in every region and product category. Management raises fiscal 2022 view.
Inter Parfums (IPAR) Ups 2021 Earnings View on Solid Q4 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2021. Management raises 2022 sales and earnings guidance.
Inter Parfums (IPAR) Up More Than 40% in 6 Months: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) is benefiting from its focus on business expansion through new licenses. The company is also on track with effective product launches.
Medifast (MED) Gains on OPTAVIA Strength, SG&A Costs Rise
by Zacks Equity Research
Medifast (MED) has been gaining on strength of its OPTAVIA lifestyle solution and coaching support system, which was a major driver in the third quarter.
Archer Daniels (ADM) Boosts Flavor Business Via Latest Buyout
by Zacks Equity Research
Archer Daniels' (ADM) recent acquisition of Flavor Infusion is set to help it expand the customer base across Latin America & the Caribbean along with drive growth in the highly-valued flavor space.
Kimberly-Clark (KMB) Looks Troubled on Escalated Input Costs
by Zacks Equity Research
Kimberly-Clark (KMB) has been encountering escalated input costs. Key input costs are estimated to escalate in the range of $1,400-$1,500 million in 2021.
Lamb Weston's (LW) Stock Falls 22% in 6 Months on Input Costs
by Zacks Equity Research
Lamb Weston (LW) has been encountering escalated input costs and high SG&A costs. For fiscal 2022, management expects net income and adjusted EBITDA to be under pressure.
Conagra (CAG) Appears to be in Trouble on Cost Inflation
by Zacks Equity Research
Conagra (CAG) has been encountering cost of goods sold, inflation and high SG&A costs. Management expects cost inflation of nearly 11% in fiscal 2022.
TreeHouse Foods (THS) Looks Troubled: High Costs a Key Concern
by Zacks Equity Research
TreeHouse Foods (THS) has been battling escalated cost inflation. Management lowered its earnings guidance for 2021 on its last earnings call.